Massively parallel characterization of transcriptional regulatory elements in three diverse human cell types.
Journal
bioRxiv : the preprint server for biology
Titre abrégé: bioRxiv
Pays: United States
ID NLM: 101680187
Informations de publication
Date de publication:
06 Mar 2023
06 Mar 2023
Historique:
pubmed:
23
3
2023
medline:
23
3
2023
entrez:
22
3
2023
Statut:
epublish
Résumé
The human genome contains millions of candidate
Identifiants
pubmed: 36945371
doi: 10.1101/2023.03.05.531189
pmc: PMC10028905
pii:
doi:
Types de publication
Preprint
Langues
eng
Subventions
Organisme : NIDDK NIH HHS
ID : P30 DK098722
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK124769
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG011966
Pays : United States
Déclaration de conflit d'intérêts
Competing interests. V.A. is an employee of Sanofi Pasteur Inc. J.S. is a scientific advisory board member, consultant and/or co-founder of Cajal Neuroscience, Guardant Health, Maze Therapeutics, Camp4 Therapeutics, Phase Genomics, Adaptive Biotechnologies, Scale Biosciences, Sixth Street Capital, and Pacific Biosciences. N.A. is the cofounder and on the scientific advisory board of Regel Therapeutics and receives funding from BioMarin Pharmaceutical Incorporated. All other authors declare no competing interests.